vs

Side-by-side financial comparison of EQUITY LIFESTYLE PROPERTIES INC (ELS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $397.6M, roughly 1.6× EQUITY LIFESTYLE PROPERTIES INC). On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 2.7%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 2.3%).

Simon Media Properties, LLC, doing business as Simon Property Group, Inc., is an American real estate investment trust that invests in shopping malls, outlet centers, and community/lifestyle centers. It is the largest owner of shopping malls in the United States and is headquartered in Indianapolis, Indiana. As of December 31, 2024, it owned interests in 232 properties.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

ELS vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.6× larger
RPRX
$622.0M
$397.6M
ELS
Growing faster (revenue YoY)
RPRX
RPRX
+2.1% gap
RPRX
4.8%
2.7%
ELS
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
2.3%
ELS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ELS
ELS
RPRX
RPRX
Revenue
$397.6M
$622.0M
Net Profit
$214.2M
Gross Margin
Operating Margin
62.4%
Net Margin
34.4%
Revenue YoY
2.7%
4.8%
Net Profit YoY
2.9%
EPS (diluted)
$0.56
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELS
ELS
RPRX
RPRX
Q1 26
$397.6M
Q4 25
$373.9M
$622.0M
Q3 25
$393.3M
$609.3M
Q2 25
$376.9M
$578.7M
Q1 25
$387.3M
$568.2M
Q4 24
$372.3M
$593.6M
Q3 24
$387.3M
$564.7M
Q2 24
$380.0M
$537.3M
Net Profit
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
$103.8M
$214.2M
Q3 25
$100.4M
$288.2M
Q2 25
$83.5M
$30.2M
Q1 25
$114.4M
$238.3M
Q4 24
$100.6M
$208.2M
Q3 24
$86.9M
$544.0M
Q2 24
$82.1M
$102.0M
Operating Margin
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
26.5%
62.4%
Q3 25
25.1%
70.1%
Q2 25
22.3%
36.3%
Q1 25
28.3%
94.0%
Q4 24
27.2%
60.9%
Q3 24
21.4%
Q2 24
21.5%
50.2%
Net Margin
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
27.8%
34.4%
Q3 25
25.5%
47.3%
Q2 25
22.2%
5.2%
Q1 25
29.5%
41.9%
Q4 24
27.0%
35.1%
Q3 24
22.4%
96.3%
Q2 24
21.6%
19.0%
EPS (diluted)
ELS
ELS
RPRX
RPRX
Q1 26
$0.56
Q4 25
$0.52
$0.49
Q3 25
$0.50
$0.67
Q2 25
$0.42
$0.07
Q1 25
$0.57
$0.55
Q4 24
$0.51
$0.46
Q3 24
$0.44
$1.21
Q2 24
$0.42
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELS
ELS
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$1.8B
$9.7B
Total Assets
$5.7M
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
$618.7M
Q3 25
$938.9M
Q2 25
$631.9M
Q1 25
$1.1B
Q4 24
$929.0M
Q3 24
$950.1M
Q2 24
$1.8B
Total Debt
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
$3.3B
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$3.2B
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Stockholders' Equity
ELS
ELS
RPRX
RPRX
Q1 26
$1.8B
Q4 25
$1.8B
$9.7B
Q3 25
$1.8B
$9.6B
Q2 25
$1.7B
$9.5B
Q1 25
$1.7B
$9.8B
Q4 24
$1.7B
$10.3B
Q3 24
$1.4B
$10.3B
Q2 24
$1.4B
$9.8B
Total Assets
ELS
ELS
RPRX
RPRX
Q1 26
$5.7M
Q4 25
$5.7B
$19.6B
Q3 25
$5.7B
$19.3B
Q2 25
$5.7B
$18.3B
Q1 25
$5.6B
$17.6B
Q4 24
$5.6B
$18.2B
Q3 24
$5.6B
$18.0B
Q2 24
$5.6B
$17.7B
Debt / Equity
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
1.91×
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
1.84×
0.74×
Q3 24
0.74×
Q2 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELS
ELS
RPRX
RPRX
Operating Cash FlowLast quarter
$827.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
$571.1M
$827.1M
Q3 25
$147.0M
$702.6M
Q2 25
$131.3M
$364.0M
Q1 25
$193.4M
$596.1M
Q4 24
$596.7M
$742.5M
Q3 24
$149.5M
$703.6M
Q2 24
$143.1M
$658.2M
Free Cash Flow
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
$334.1M
Q3 25
$75.7M
Q2 25
$71.8M
Q1 25
$148.2M
Q4 24
$355.4M
Q3 24
$91.1M
Q2 24
$80.6M
FCF Margin
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
89.4%
Q3 25
19.3%
Q2 25
19.1%
Q1 25
38.3%
Q4 24
95.5%
Q3 24
23.5%
Q2 24
21.2%
Capex Intensity
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
63.4%
Q3 25
18.1%
Q2 25
15.8%
Q1 25
11.7%
Q4 24
64.8%
Q3 24
15.1%
Q2 24
16.5%
Cash Conversion
ELS
ELS
RPRX
RPRX
Q1 26
Q4 25
5.50×
3.86×
Q3 25
1.46×
2.44×
Q2 25
1.57×
12.06×
Q1 25
1.69×
2.50×
Q4 24
5.93×
3.57×
Q3 24
1.72×
1.29×
Q2 24
1.74×
6.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELS
ELS

Rental income$339.0M85%
Other$37.2M9%
Annual membership subscriptions$18.3M5%
Membership upgrade revenue$3.1M1%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons